▶ 調査レポート

世界のフェンヘキサミド市場 2028年:純度≥98%、純度≥99%

• 英文タイトル:Global Fenhexamid Market Insights, Forecast to 2028

Global Fenhexamid Market Insights, Forecast to 2028「世界のフェンヘキサミド市場 2028年:純度≥98%、純度≥99%」(市場規模、市場予測)調査レポートです。• レポートコード:QY2207C0370
• 出版社/出版日:QYResearch / 2022年7月15日
• レポート形態:英文、PDF、96ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のフェンヘキサミドの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にフェンヘキサミドの世界市場のxxx%を占める「純度≥98%」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「殺菌剤」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のフェンヘキサミドの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのフェンヘキサミド市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのフェンヘキサミド市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

フェンヘキサミドのグローバル主要メーカーには、Didu Group、Bayer、Hengrun Chemical、Generic Chemical、Rayfull Chemicalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

フェンヘキサミド市場は、種類と用途によって区分されます。世界のフェンヘキサミド市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
純度≥98%、純度≥99%

【用途別セグメント】
殺菌剤、苗処理、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- フェンヘキサミド製品概要
- 種類別市場(純度≥98%、純度≥99%)
- 用途別市場(殺菌剤、苗処理、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のフェンヘキサミド販売量予測2017-2028
- 世界のフェンヘキサミド売上予測2017-2028
- フェンヘキサミドの地域別販売量
- フェンヘキサミドの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別フェンヘキサミド販売量
- 主要メーカー別フェンヘキサミド売上
- 主要メーカー別フェンヘキサミド価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(純度≥98%、純度≥99%)
- フェンヘキサミドの種類別販売量
- フェンヘキサミドの種類別売上
- フェンヘキサミドの種類別価格
・用途別市場規模(殺菌剤、苗処理、その他)
- フェンヘキサミドの用途別販売量
- フェンヘキサミドの用途別売上
- フェンヘキサミドの用途別価格
・北米市場
- 北米のフェンヘキサミド市場規模(種類別、用途別)
- 主要国別のフェンヘキサミド市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのフェンヘキサミド市場規模(種類別、用途別)
- 主要国別のフェンヘキサミド市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のフェンヘキサミド市場規模(種類別、用途別)
- 主要国別のフェンヘキサミド市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のフェンヘキサミド市場規模(種類別、用途別)
- 主要国別のフェンヘキサミド市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのフェンヘキサミド市場規模(種類別、用途別)
- 主要国別のフェンヘキサミド市場規模(トルコ、サウジアラビア)
・企業情報
Didu Group、Bayer、Hengrun Chemical、Generic Chemical、Rayfull Chemicals
・産業チェーン及び販売チャネル分析
- フェンヘキサミドの産業チェーン分析
- フェンヘキサミドの原材料
- フェンヘキサミドの生産プロセス
- フェンヘキサミドの販売及びマーケティング
- フェンヘキサミドの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- フェンヘキサミドの産業動向
- フェンヘキサミドのマーケットドライバー
- フェンヘキサミドの課題
- フェンヘキサミドの阻害要因
・主な調査結果

Market Analysis and Insights: Global Fenhexamid Market
Due to the COVID-19 pandemic, the global Fenhexamid market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥98% accounting for % of the Fenhexamid global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Fungicide segment is altered to an % CAGR throughout this forecast period.
China Fenhexamid market size is valued at US$ million in 2021, while the US and Europe Fenhexamid are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Fenhexamid landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Fenhexamid include Didu Group, Bayer, Hengrun Chemical, Generic Chemical and Rayfull Chemicals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Fenhexamid capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Fenhexamid by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Fenhexamid Scope and Segment
Fenhexamid market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Fenhexamid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity ≥98%
Purity ≥99%
Segment by Application
Fungicide
Seedling Treatment
Other
By Company
Didu Group
Bayer
Hengrun Chemical
Generic Chemical
Rayfull Chemicals
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Fenhexamid Product Introduction
1.2 Market by Type
1.2.1 Global Fenhexamid Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ≥98%
1.2.3 Purity ≥99%
1.3 Market by Application
1.3.1 Global Fenhexamid Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Fungicide
1.3.3 Seedling Treatment
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Fenhexamid Production
2.1 Global Fenhexamid Production Capacity (2017-2028)
2.2 Global Fenhexamid Production by Region: 2017 VS 2021 VS 2028
2.3 Global Fenhexamid Production by Region
2.3.1 Global Fenhexamid Historic Production by Region (2017-2022)
2.3.2 Global Fenhexamid Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Fenhexamid Sales in Volume & Value Estimates and Forecasts
3.1 Global Fenhexamid Sales Estimates and Forecasts 2017-2028
3.2 Global Fenhexamid Revenue Estimates and Forecasts 2017-2028
3.3 Global Fenhexamid Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Fenhexamid Sales by Region
3.4.1 Global Fenhexamid Sales by Region (2017-2022)
3.4.2 Global Sales Fenhexamid by Region (2023-2028)
3.5 Global Fenhexamid Revenue by Region
3.5.1 Global Fenhexamid Revenue by Region (2017-2022)
3.5.2 Global Fenhexamid Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Fenhexamid Production Capacity by Manufacturers
4.2 Global Fenhexamid Sales by Manufacturers
4.2.1 Global Fenhexamid Sales by Manufacturers (2017-2022)
4.2.2 Global Fenhexamid Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Fenhexamid in 2021
4.3 Global Fenhexamid Revenue by Manufacturers
4.3.1 Global Fenhexamid Revenue by Manufacturers (2017-2022)
4.3.2 Global Fenhexamid Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Fenhexamid Revenue in 2021
4.4 Global Fenhexamid Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Fenhexamid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Fenhexamid Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Fenhexamid Sales by Type
5.1.1 Global Fenhexamid Historical Sales by Type (2017-2022)
5.1.2 Global Fenhexamid Forecasted Sales by Type (2023-2028)
5.1.3 Global Fenhexamid Sales Market Share by Type (2017-2028)
5.2 Global Fenhexamid Revenue by Type
5.2.1 Global Fenhexamid Historical Revenue by Type (2017-2022)
5.2.2 Global Fenhexamid Forecasted Revenue by Type (2023-2028)
5.2.3 Global Fenhexamid Revenue Market Share by Type (2017-2028)
5.3 Global Fenhexamid Price by Type
5.3.1 Global Fenhexamid Price by Type (2017-2022)
5.3.2 Global Fenhexamid Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Fenhexamid Sales by Application
6.1.1 Global Fenhexamid Historical Sales by Application (2017-2022)
6.1.2 Global Fenhexamid Forecasted Sales by Application (2023-2028)
6.1.3 Global Fenhexamid Sales Market Share by Application (2017-2028)
6.2 Global Fenhexamid Revenue by Application
6.2.1 Global Fenhexamid Historical Revenue by Application (2017-2022)
6.2.2 Global Fenhexamid Forecasted Revenue by Application (2023-2028)
6.2.3 Global Fenhexamid Revenue Market Share by Application (2017-2028)
6.3 Global Fenhexamid Price by Application
6.3.1 Global Fenhexamid Price by Application (2017-2022)
6.3.2 Global Fenhexamid Price Forecast by Application (2023-2028)
7 North America
7.1 North America Fenhexamid Market Size by Type
7.1.1 North America Fenhexamid Sales by Type (2017-2028)
7.1.2 North America Fenhexamid Revenue by Type (2017-2028)
7.2 North America Fenhexamid Market Size by Application
7.2.1 North America Fenhexamid Sales by Application (2017-2028)
7.2.2 North America Fenhexamid Revenue by Application (2017-2028)
7.3 North America Fenhexamid Sales by Country
7.3.1 North America Fenhexamid Sales by Country (2017-2028)
7.3.2 North America Fenhexamid Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Fenhexamid Market Size by Type
8.1.1 Europe Fenhexamid Sales by Type (2017-2028)
8.1.2 Europe Fenhexamid Revenue by Type (2017-2028)
8.2 Europe Fenhexamid Market Size by Application
8.2.1 Europe Fenhexamid Sales by Application (2017-2028)
8.2.2 Europe Fenhexamid Revenue by Application (2017-2028)
8.3 Europe Fenhexamid Sales by Country
8.3.1 Europe Fenhexamid Sales by Country (2017-2028)
8.3.2 Europe Fenhexamid Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Fenhexamid Market Size by Type
9.1.1 Asia Pacific Fenhexamid Sales by Type (2017-2028)
9.1.2 Asia Pacific Fenhexamid Revenue by Type (2017-2028)
9.2 Asia Pacific Fenhexamid Market Size by Application
9.2.1 Asia Pacific Fenhexamid Sales by Application (2017-2028)
9.2.2 Asia Pacific Fenhexamid Revenue by Application (2017-2028)
9.3 Asia Pacific Fenhexamid Sales by Region
9.3.1 Asia Pacific Fenhexamid Sales by Region (2017-2028)
9.3.2 Asia Pacific Fenhexamid Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Fenhexamid Market Size by Type
10.1.1 Latin America Fenhexamid Sales by Type (2017-2028)
10.1.2 Latin America Fenhexamid Revenue by Type (2017-2028)
10.2 Latin America Fenhexamid Market Size by Application
10.2.1 Latin America Fenhexamid Sales by Application (2017-2028)
10.2.2 Latin America Fenhexamid Revenue by Application (2017-2028)
10.3 Latin America Fenhexamid Sales by Country
10.3.1 Latin America Fenhexamid Sales by Country (2017-2028)
10.3.2 Latin America Fenhexamid Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Fenhexamid Market Size by Type
11.1.1 Middle East and Africa Fenhexamid Sales by Type (2017-2028)
11.1.2 Middle East and Africa Fenhexamid Revenue by Type (2017-2028)
11.2 Middle East and Africa Fenhexamid Market Size by Application
11.2.1 Middle East and Africa Fenhexamid Sales by Application (2017-2028)
11.2.2 Middle East and Africa Fenhexamid Revenue by Application (2017-2028)
11.3 Middle East and Africa Fenhexamid Sales by Country
11.3.1 Middle East and Africa Fenhexamid Sales by Country (2017-2028)
11.3.2 Middle East and Africa Fenhexamid Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Didu Group
12.1.1 Didu Group Corporation Information
12.1.2 Didu Group Overview
12.1.3 Didu Group Fenhexamid Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Didu Group Fenhexamid Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Didu Group Recent Developments
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Overview
12.2.3 Bayer Fenhexamid Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Bayer Fenhexamid Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Bayer Recent Developments
12.3 Hengrun Chemical
12.3.1 Hengrun Chemical Corporation Information
12.3.2 Hengrun Chemical Overview
12.3.3 Hengrun Chemical Fenhexamid Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Hengrun Chemical Fenhexamid Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Hengrun Chemical Recent Developments
12.4 Generic Chemical
12.4.1 Generic Chemical Corporation Information
12.4.2 Generic Chemical Overview
12.4.3 Generic Chemical Fenhexamid Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Generic Chemical Fenhexamid Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Generic Chemical Recent Developments
12.5 Rayfull Chemicals
12.5.1 Rayfull Chemicals Corporation Information
12.5.2 Rayfull Chemicals Overview
12.5.3 Rayfull Chemicals Fenhexamid Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Rayfull Chemicals Fenhexamid Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Rayfull Chemicals Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Fenhexamid Industry Chain Analysis
13.2 Fenhexamid Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Fenhexamid Production Mode & Process
13.4 Fenhexamid Sales and Marketing
13.4.1 Fenhexamid Sales Channels
13.4.2 Fenhexamid Distributors
13.5 Fenhexamid Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Fenhexamid Industry Trends
14.2 Fenhexamid Market Drivers
14.3 Fenhexamid Market Challenges
14.4 Fenhexamid Market Restraints
15 Key Finding in The Global Fenhexamid Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer